Literature DB >> 2155967

Monoclonal antibodies from Epstein-Barr virus-transformed lymphocytes of common marmosets (Callithrix jacchus) immune to malaria.

D A Johnston1, A M Knight, B A Naylor, N Wedderburn, G H Mitchell.   

Abstract

The B lymphocytes of the common marmoset Callithrix jacchus can be immortalized by infection with Epstein-Barr virus (EBV) in vitro (Desgranges et al., 1976). C. jacchus is susceptible to infection with the blood stages of several species of malaria parasite including the line designated MVF1 (Mitchell et al., 1988) from which it recovers and shows immunity to reinfection. By exploiting these two phenomena, EBV-transformed, marmoset lymphoblastoid cell lines secreting antibodies to malaria parasite antigens have been generated and cloned. We believe this to be the first time that monoclonal antibodies (MAbs) have been raised from common marmosets. Since numerous and diverse human pathogens can infect this small primate in the laboratory, these methods may prove generally applicable for the generation of MAbs whose specificities derive from immune responses to infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155967      PMCID: PMC7130502          DOI: 10.1016/0022-1759(90)90068-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  29 in total

1.  Requirements for growth of Epstein-Barr virus-transformed cells at low cell densities.

Authors:  R F Tiebout; R W Sauerwein; W G van der Meer; F van Boxtel-Oosterhof; W P Zeijlemaker
Journal:  Immunology       Date:  1987-02       Impact factor: 7.397

2.  HIV infection of primate lymphocytes and conservation of the CD4 receptor.

Authors:  M O McClure; Q J Sattentau; P C Beverley; J P Hearn; A K Fitzgerald; A J Zuckerman; R A Weiss
Journal:  Nature       Date:  1987 Dec 3-9       Impact factor: 49.962

3.  Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus.

Authors:  J H Pope; M K Horne; W Scott
Journal:  Int J Cancer       Date:  1968-11-15       Impact factor: 7.396

4.  [Reactivity of 48-1 antibody with human liver tissue].

Authors:  H Unoki
Journal:  J UOEH       Date:  1987-12-01

5.  Protection of Junín virus-infected marmosets by passive administration of immune serum: association with late neurologic signs.

Authors:  M M Avila; S R Samoilovich; R P Laguens; M S Merani; M C Weissenbacher
Journal:  J Med Virol       Date:  1987-01       Impact factor: 2.327

6.  Oral infection of a common marmoset with human T-cell leukemia virus type-I (HTLV-I) by inoculating fresh human milk of HTLV-I carrier mothers.

Authors:  K Kinoshita; K Yamanouchi; S Ikeda; S Momita; T Amagasaki; H Soda; M Ichimaru; R Moriuchi; S Katamine; T Miyamoto
Journal:  Jpn J Cancer Res       Date:  1985-12

7.  In vitro transforming activity of EBV. I-Establishment and properties of two EBV strains (M81 and M72) produced by immortalized Callithrix jacchus lymphocytes.

Authors:  C Desgranges; G Lenoir; G de-Thé; J M Seigneurin; J Hilgers; P Dubouch
Journal:  Biomedicine       Date:  1976-12-05

8.  Immunization of marmosets with Trypanosoma cruzi cell surface glycoprotein (GP90).

Authors:  M T Scott; R A Neal; N C Woods
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

9.  Biosynthesis and processing of a Plasmodium falciparum schizont antigen recognized by immune serum and a monoclonal antibody.

Authors:  A A Holder; R R Freeman
Journal:  J Exp Med       Date:  1982-11-01       Impact factor: 14.307

10.  Coronavirus-like particles and Campylobacter in marmosets with diarrhea and colitis.

Authors:  R G Russell; D A Brian; A Lenhard; L N Potgieter; D Gillespie; N K Clapp
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

View more
  1 in total

1.  Human T cell responses to beta-galactosidase.

Authors:  J D Oxley; R H Brookes; L S Rayfield; P S Shepherd
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.